PE20060359A1 - Prodrogas de estradiol - Google Patents

Prodrogas de estradiol

Info

Publication number: PE20060359A1
Authority: PE; Peru
Prior art keywords: ilo; trien; prodrogs; estradiol; sulfamoylbenzoate
Prior art date: 2004-05-21

Application number

PE2005000557A

Other languages

English (en)

Spanish (es)

Inventor

Peter Droescher

Walter Elger

Alexander Hillisch

Gudrun Reddersen

Ralf Wyrwa

Sven Ring

Birgitt Schneider

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-21

Filing date

2005-05-20

Publication date

2006-05-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34969196&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060359(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-20 Application filed by Schering Ag filed Critical Schering Ag

2006-05-25 Publication of PE20060359A1 publication Critical patent/PE20060359A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PE2005000557A 2004-05-21 2005-05-20 Prodrogas de estradiol PE20060359A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004025966A DE102004025966A1 (de)	2004-05-21	2004-05-21	Estradiol-Prodrugs

Publications (1)

Publication Number	Publication Date
PE20060359A1 true PE20060359A1 (es)	2006-05-25

Family

ID=34969196

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE2005000557A PE20060359A1 (es)	2004-05-21	2005-05-20	Prodrogas de estradiol

Country Status (11)

Country	Link
EP (1)	EP1747230A1 (fr)
JP (1)	JP2007538025A (fr)
AR (1)	AR050335A1 (fr)
DE (1)	DE102004025966A1 (fr)
GT (1)	GT200500121A (fr)
PA (1)	PA8633701A1 (fr)
PE (1)	PE20060359A1 (fr)
SV (1)	SV2006002121A (fr)
TW (1)	TW200613315A (fr)
UY (1)	UY28909A1 (fr)
WO (1)	WO2005113574A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10027887A1 (de)	2000-05-31	2001-12-13	Jenapharm Gmbh	Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en)	2004-05-21	2009-05-19	Bayer Schering Pharma Aktiengesellschaft	Estradiol prodrugs
DE102004025985A1 (de) *	2004-05-21	2005-12-15	Schering Ag	Estriol- und Estetrol-Prodrugs
DE102005057224A1 (de) *	2005-11-29	2007-05-31	Bayer Schering Pharma Ag	Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057225A1 (de) *	2005-11-29	2007-05-31	Bayer Schering Pharma Ag	Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) *	2005-11-30	2007-05-31	Bayer Schering Pharma Ag	Sulfamoylsulfonat-Prodrugs
US9745338B2 (en) *	2013-07-11	2017-08-29	Evestra, Inc.	Pro-drug forming compounds
CN115368427B (zh) *	2022-08-17	2024-02-13	南宁师范大学	雌二醇硒氰酸酯类化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1238739A (fr) *	1958-08-04	1960-08-19	Chimiotherapie Lab Franc	Procédé de préparation de dérivés hydrosolubles de testostérone
FR8290M (fr) *	1968-12-31	1970-11-09	Rech Chimiques Et Ind Mar Lab
US5001234A (en) *	1987-04-16	1991-03-19	The Upjohn Company	Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) *	1994-11-17	1996-11-05	Duquesne University Of The Holy Ghost	Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) *	1997-03-25	1998-10-01	Knoell Hans Forschung Ev	Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
EP1284272A4 (fr) *	2000-04-24	2003-09-10	Kyowa Hakko Kogyo Kk	Derives d'estra-1,3,5(10)-triene
DE10027887A1 (de) *	2000-05-31	2001-12-13	Jenapharm Gmbh	Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0015876D0 (en) *	2000-06-28	2000-08-23	Novartis Ag	Organic compounds
GB0316290D0 (en) *	2003-07-11	2003-08-13	Glaxo Group Ltd	Novel compounds
TWI331154B (en) *	2003-11-12	2010-10-01	Solvay Pharm Gmbh	Novel 17-hydroxysteroid dehydrogenase type i inhibitors
DE102004025985A1 (de) *	2004-05-21	2005-12-15	Schering Ag	Estriol- und Estetrol-Prodrugs

2004
- 2004-05-21 DE DE102004025966A patent/DE102004025966A1/de not_active Withdrawn
2005
- 2005-05-10 JP JP2007517046A patent/JP2007538025A/ja active Pending
- 2005-05-10 EP EP05747458A patent/EP1747230A1/fr not_active Withdrawn
- 2005-05-10 WO PCT/EP2005/005254 patent/WO2005113574A1/fr not_active Ceased
- 2005-05-19 UY UY28909A patent/UY28909A1/es not_active Application Discontinuation
- 2005-05-20 AR ARP050102083A patent/AR050335A1/es unknown
- 2005-05-20 TW TW094116503A patent/TW200613315A/zh unknown
- 2005-05-20 PA PA20058633701A patent/PA8633701A1/es unknown
- 2005-05-20 GT GT200500121A patent/GT200500121A/es unknown
- 2005-05-20 PE PE2005000557A patent/PE20060359A1/es not_active Application Discontinuation
- 2005-05-23 SV SV2005002121A patent/SV2006002121A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2005113574A1 (fr)	2005-12-01
DE102004025966A1 (de)	2005-12-15
JP2007538025A (ja)	2007-12-27
SV2006002121A (es)	2006-02-15
PA8633701A1 (es)	2006-07-03
UY28909A1 (es)	2005-12-30
GT200500121A (es)	2006-01-30
TW200613315A (en)	2006-05-01
AR050335A1 (es)	2006-10-18
EP1747230A1 (fr)	2007-01-31

Publication	Publication Date	Title
DE60112974D1 (en)	2005-09-29	Carbolinderivate
NO20035327D0 (no)	2003-11-28	Biologisk aktive metylen-blått derivater
NO20052787L (no)	2005-06-09	N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE487493T1 (de)	2010-11-15	Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
ATE451381T1 (de)	2009-12-15	Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
EP1771454A4 (fr)	2009-05-13	Analogues peptidiques inhibiteurs de l'hepatite c
UA93351C2 (uk)	2011-02-10	Похідні фталазіну як інгібітори parp
GEP20104960B (en)	2010-04-26	USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN
DK1501507T3 (da)	2008-09-29	Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
MXPA04004347A (es)	2004-08-11	Nuevos fotoindicadores difuncionales.
ATE403429T1 (de)	2008-08-15	Spiropyrazol-verbindungen
DE60216233D1 (en)	2007-01-04	Carbolinderivate
SE0004245D0 (sv)	2000-11-20	Novel compounds and their use
MXPA03002911A (es)	2003-09-10	Compuestos quimicos.
EA200501690A1 (ru)	2006-06-30	Композиция, включающая ингибитор pde4 и ингибитор pde5
MXPA02012659A (es)	2003-09-22	Derivados de pirazindiona condensados.
ATE511352T1 (de)	2011-06-15	Antimikrobielle zusammensetzungen
ATE457977T1 (de)	2010-03-15	Biguanidderivate
PE20060359A1 (es)	2006-05-25	Prodrogas de estradiol
EA200401095A1 (ru)	2005-02-24	Окса-и тиадиазолы и их применение в качестве ингибиторов металлопротеиназ
ECSP077130A (es)	2007-02-28	Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
EP1656127A4 (fr)	2009-04-29	Composes pour le traitement de troubles metaboliques
DE60112960D1 (de)	2005-09-29	Kondensierte pyridoindolderivate
SE9903290D0 (sv)	1999-09-15	Novel compounds
DE60121048D1 (de)	2006-08-03	PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE

Legal Events

Date	Code	Title	Description
2008-08-07	FG	Grant, registration
2009-12-29	FD	Application declared void or lapsed